Tempus AI (TEM) announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology, ACC, Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus is presenting research, all of which highlights the application of AI to support clinicians in delivering personalized care. “Tempus is committed to enabling clinicians to provide better, guideline-recommended care to patients who may have undiagnosed or undertreated cardiovascular disease,” said Brandon Fornwalt, MD, PhD, Senior Vice President of Cardiology at Tempus. “Through our vast connected network of providers and ability to deliver AI-enabled insights at scale, we can help clinicians close care gaps for patients in a way that wasn’t possible before.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Largest borrow rate increases among liquid names
- Cathie Wood’s ARK Sells over $7M Worth of META Stock but Adds GitLab and Tempus AI
- Cathie Wood’s ARK Investment bought 171K shares of Tempus AI today
- Cathie Wood Adds 30K More Tempus AI Stock Following Deep 6 AI Buyout News
- Cathie Wood’s ARK Investment bought 30K shares of Tempus AI today